BR0016291A - Composto, uso do mesmo, métodos para a inibição das relaxações do esfìncter esofágico inferior transientes, para o tratamento da doença do refluxo gastroesofágico, da regurgitação em bebês, de nocicepção, êmese, dispepsia, ibs, soluços, adicção de cocaìna, dor, tosse, eructação, asma relacionada ou não com gord, e, formulação farmacêutica - Google Patents
Composto, uso do mesmo, métodos para a inibição das relaxações do esfìncter esofágico inferior transientes, para o tratamento da doença do refluxo gastroesofágico, da regurgitação em bebês, de nocicepção, êmese, dispepsia, ibs, soluços, adicção de cocaìna, dor, tosse, eructação, asma relacionada ou não com gord, e, formulação farmacêuticaInfo
- Publication number
- BR0016291A BR0016291A BR0016291-4A BR0016291A BR0016291A BR 0016291 A BR0016291 A BR 0016291A BR 0016291 A BR0016291 A BR 0016291A BR 0016291 A BR0016291 A BR 0016291A
- Authority
- BR
- Brazil
- Prior art keywords
- disease
- health
- amino
- eructation
- cough
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 206010011224 Cough Diseases 0.000 title abstract 2
- 206010015137 Eructation Diseases 0.000 title abstract 2
- 208000006673 asthma Diseases 0.000 title abstract 2
- 208000021302 gastroesophageal reflux disease Diseases 0.000 title abstract 2
- 230000001052 transient effect Effects 0.000 title abstract 2
- 208000022497 Cocaine-Related disease Diseases 0.000 title 1
- 208000031361 Hiccup Diseases 0.000 title 1
- 208000002193 Pain Diseases 0.000 title 1
- 206010067171 Regurgitation Diseases 0.000 title 1
- 206010047700 Vomiting Diseases 0.000 title 1
- 201000006145 cocaine dependence Diseases 0.000 title 1
- 206010013663 drug dependence Diseases 0.000 title 1
- 201000006549 dyspepsia Diseases 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 210000000111 lower esophageal sphincter Anatomy 0.000 title 1
- 230000020341 sensory perception of pain Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 5
- VWJSZVQNMVAGBU-UHFFFAOYSA-N NCC(CCP(O)(O)=O)O Chemical compound NCC(CCP(O)(O)=O)O VWJSZVQNMVAGBU-UHFFFAOYSA-N 0.000 abstract 2
- CJTIGOOCRLKWAP-UHFFFAOYSA-N (3-amino-2-oxopropyl)-methylphosphinic acid Chemical compound CP(O)(=O)CC(=O)CN CJTIGOOCRLKWAP-UHFFFAOYSA-N 0.000 abstract 1
- XYKLUVLJHSTFHU-UHFFFAOYSA-N (4-amino-1,1-difluoro-3-hydroxybutyl)phosphonic acid Chemical compound NCC(CC(P(O)(O)=O)(F)F)O XYKLUVLJHSTFHU-UHFFFAOYSA-N 0.000 abstract 1
- 230000033228 biological regulation Effects 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9904507A SE9904507D0 (sv) | 1999-12-09 | 1999-12-09 | New compounds |
| PCT/SE2000/002427 WO2001041743A1 (en) | 1999-12-09 | 2000-12-04 | New (aminopropyl)methylphosphinic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0016291A true BR0016291A (pt) | 2002-08-13 |
Family
ID=20418062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0016291-4A BR0016291A (pt) | 1999-12-09 | 2000-12-04 | Composto, uso do mesmo, métodos para a inibição das relaxações do esfìncter esofágico inferior transientes, para o tratamento da doença do refluxo gastroesofágico, da regurgitação em bebês, de nocicepção, êmese, dispepsia, ibs, soluços, adicção de cocaìna, dor, tosse, eructação, asma relacionada ou não com gord, e, formulação farmacêutica |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6596711B1 (https=) |
| EP (1) | EP1239843A1 (https=) |
| JP (1) | JP2003516346A (https=) |
| KR (1) | KR100752010B1 (https=) |
| CN (1) | CN1200713C (https=) |
| AR (1) | AR033350A1 (https=) |
| AU (1) | AU780259B2 (https=) |
| BR (1) | BR0016291A (https=) |
| CA (1) | CA2393510A1 (https=) |
| CO (1) | CO5261538A1 (https=) |
| CZ (1) | CZ20021984A3 (https=) |
| EE (1) | EE200200287A (https=) |
| HU (1) | HUP0300386A3 (https=) |
| IL (2) | IL150090A0 (https=) |
| IS (1) | IS6409A (https=) |
| MX (1) | MXPA02005537A (https=) |
| NO (1) | NO20022729L (https=) |
| NZ (1) | NZ519377A (https=) |
| PL (1) | PL357115A1 (https=) |
| RU (1) | RU2267495C2 (https=) |
| SE (1) | SE9904507D0 (https=) |
| SK (1) | SK7632002A3 (https=) |
| TW (1) | TWI225415B (https=) |
| UA (1) | UA73149C2 (https=) |
| WO (1) | WO2001041743A1 (https=) |
| ZA (1) | ZA200204122B (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7319095B2 (en) * | 1999-12-09 | 2008-01-15 | Astrazeneca Ab | Use of GABAB receptor agonists |
| SE9904508D0 (sv) * | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
| TW200407110A (en) | 2001-11-23 | 2004-05-16 | Astrazeneca Ab | New use for the treatment of gastroesophageal reflux disease |
| SE0201939D0 (sv) * | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | New combination |
| SE0201940D0 (sv) * | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | New combination II |
| DE10305463A1 (de) * | 2003-02-04 | 2004-08-12 | Schering Ag | Enantiomerenreines (4S,8S)- und (4R,8R)-4-p-Nitrobenzyl-8-methyl-3,6,9-triza-3N,6N,9N-tricarboxymethyl-1,11-undecandisäure und deren Abkömmlinge, Verfahren zu deren Herstellung und Verwendung zur Herstellung pharmazeutischer Mittel |
| SE0401653D0 (sv) | 2004-06-24 | 2004-06-24 | Astrazeneca Ab | New compounds |
| SE0402462D0 (sv) * | 2004-10-08 | 2004-10-08 | Astrazeneca Ab | New process |
| CA2632021A1 (en) | 2005-12-23 | 2007-06-28 | Astrazeneca Ab | Gaba-b receptor modulators |
| JP2009521428A (ja) | 2005-12-23 | 2009-06-04 | アストラゼネカ・アクチエボラーグ | 胃腸疾患治療用のイミダゾール誘導体 |
| ES2373255T3 (es) | 2007-05-04 | 2012-02-01 | Astrazeneca Ab | Proceso para s�?ntesis de �?cidos alquilfosf�?nicos mediante iniciación de una amina y un aminóxido. |
| EP2217245A4 (en) * | 2007-07-25 | 2011-01-12 | Astrazeneca Ab | USE OF (3-AMINO-2-FLUOROPROPYL) -PHOSPHIC ACID FOR THE TREATMENT OF NERD |
| WO2009082344A1 (en) * | 2007-12-21 | 2009-07-02 | Astrazeneca Ab | Novel process for making (2r)-(3-amino-2-fluoropropyl)phosphinic acid form a |
| WO2009082345A1 (en) * | 2007-12-21 | 2009-07-02 | Astrazeneca Ab | Novel crystalline form b of (2r)-(3-amino-2-fluoropropyl)phosphinic acid |
| JP2011026260A (ja) * | 2009-07-28 | 2011-02-10 | Central Glass Co Ltd | ３位に脱離基を有する２−フルオロプロピルアミン保護体または該アミンｎ−アルキル保護体 |
| WO2011113904A1 (en) | 2010-03-17 | 2011-09-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH449046A (de) | 1963-07-09 | 1967-12-31 | Ciba Geigy | Verfahren zur Herstellung neuer Aminosäuren |
| SU643510A1 (ru) * | 1975-04-11 | 1979-01-25 | Предприятие П/Я А-7815 | Способ получени о-аминофениларилфосфиновых кислот |
| SU589756A1 (ru) * | 1976-01-23 | 1982-10-07 | Институт Органической Химии Ан Усср | Способ получени солей перфторалкилфосфиновых кислот |
| GB8425872D0 (en) | 1984-10-12 | 1984-11-21 | Ciba Geigy Ag | Chemical compounds |
| EP0250572A1 (en) | 1986-01-03 | 1988-01-07 | The University Of Melbourne | Gastro-oesophageal reflux composition |
| GB8820266D0 (en) | 1988-08-26 | 1988-09-28 | Smith Kline French Lab | Compounds |
| US5567840A (en) * | 1989-05-13 | 1996-10-22 | Ciba-Geigy Corporation | Substituted aminoalkylphosphinic acids |
| US5281747A (en) * | 1989-05-13 | 1994-01-25 | Ciba-Geigy Corporation | Substituted aminoalkylphosphinic acids |
| GB8911017D0 (en) | 1989-05-13 | 1989-06-28 | Ciba Geigy Ag | Substituted aminoalkylphosphinic acids |
| FR2663934B1 (fr) | 1990-06-27 | 1994-06-03 | Adir | Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent. |
| FR2722192A1 (fr) | 1994-07-06 | 1996-01-12 | Adir | Nouveaux derives de l'acide 4-amino butyrique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB9420784D0 (en) | 1994-10-14 | 1994-11-30 | Glaxo Group Ltd | Medicaments |
| SE9603408D0 (sv) * | 1996-09-18 | 1996-09-18 | Astra Ab | Medical use |
-
1999
- 1999-12-09 SE SE9904507A patent/SE9904507D0/xx unknown
-
2000
- 2000-04-12 UA UA2002064506A patent/UA73149C2/uk unknown
- 2000-11-27 TW TW089125146A patent/TWI225415B/zh not_active IP Right Cessation
- 2000-12-04 EE EEP200200287A patent/EE200200287A/xx unknown
- 2000-12-04 CA CA002393510A patent/CA2393510A1/en not_active Abandoned
- 2000-12-04 WO PCT/SE2000/002427 patent/WO2001041743A1/en not_active Ceased
- 2000-12-04 SK SK763-2002A patent/SK7632002A3/sk not_active Application Discontinuation
- 2000-12-04 US US09/786,220 patent/US6596711B1/en not_active Expired - Fee Related
- 2000-12-04 NZ NZ519377A patent/NZ519377A/en unknown
- 2000-12-04 RU RU2002113916/04A patent/RU2267495C2/ru not_active Application Discontinuation
- 2000-12-04 JP JP2001543088A patent/JP2003516346A/ja active Pending
- 2000-12-04 KR KR1020027007356A patent/KR100752010B1/ko not_active Expired - Fee Related
- 2000-12-04 IL IL15009000A patent/IL150090A0/xx active IP Right Grant
- 2000-12-04 EP EP00986117A patent/EP1239843A1/en not_active Withdrawn
- 2000-12-04 MX MXPA02005537A patent/MXPA02005537A/es active IP Right Grant
- 2000-12-04 CN CNB008169063A patent/CN1200713C/zh not_active Expired - Fee Related
- 2000-12-04 BR BR0016291-4A patent/BR0016291A/pt not_active Application Discontinuation
- 2000-12-04 HU HU0300386A patent/HUP0300386A3/hu unknown
- 2000-12-04 CZ CZ20021984A patent/CZ20021984A3/cs unknown
- 2000-12-04 AU AU22412/01A patent/AU780259B2/en not_active Ceased
- 2000-12-04 PL PL00357115A patent/PL357115A1/xx not_active IP Right Cessation
- 2000-12-05 AR ARP000106429A patent/AR033350A1/es unknown
- 2000-12-06 CO CO00093168A patent/CO5261538A1/es not_active Application Discontinuation
-
2002
- 2002-05-23 ZA ZA200204122A patent/ZA200204122B/xx unknown
- 2002-06-06 IS IS6409A patent/IS6409A/is unknown
- 2002-06-06 IL IL150090A patent/IL150090A/en not_active IP Right Cessation
- 2002-06-07 NO NO20022729A patent/NO20022729L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ519377A (en) | 2003-11-28 |
| UA73149C2 (en) | 2005-06-15 |
| CN1200713C (zh) | 2005-05-11 |
| CO5261538A1 (es) | 2003-03-31 |
| IS6409A (is) | 2002-06-06 |
| IL150090A (en) | 2006-08-01 |
| EP1239843A1 (en) | 2002-09-18 |
| JP2003516346A (ja) | 2003-05-13 |
| ZA200204122B (en) | 2003-10-29 |
| US6596711B1 (en) | 2003-07-22 |
| CA2393510A1 (en) | 2001-06-14 |
| CN1413104A (zh) | 2003-04-23 |
| NO20022729L (no) | 2002-07-09 |
| HK1053066A1 (en) | 2003-10-10 |
| SK7632002A3 (en) | 2003-03-04 |
| SE9904507D0 (sv) | 1999-12-09 |
| RU2002113916A (ru) | 2004-01-10 |
| RU2267495C2 (ru) | 2006-01-10 |
| AU2241201A (en) | 2001-06-18 |
| WO2001041743A1 (en) | 2001-06-14 |
| PL357115A1 (en) | 2004-07-12 |
| MXPA02005537A (es) | 2004-09-10 |
| AU780259B2 (en) | 2005-03-10 |
| HUP0300386A2 (hu) | 2003-07-28 |
| AR033350A1 (es) | 2003-12-17 |
| IL150090A0 (en) | 2002-12-01 |
| NO20022729D0 (no) | 2002-06-07 |
| KR100752010B1 (ko) | 2007-08-28 |
| KR20020060993A (ko) | 2002-07-19 |
| CZ20021984A3 (cs) | 2002-11-13 |
| TWI225415B (en) | 2004-12-21 |
| EE200200287A (et) | 2003-08-15 |
| HUP0300386A3 (en) | 2005-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0016253A (pt) | Composto, uso de um composto, métodos para a inibição dos relaxamentos do esfìncter esofágico inferior transientes para o tratamento da doença do refluxo gastroesofágico, da regurgitação em bebês, de nocicepção, êmese. dispepsia, ibs, soluções, adicção em cocaìna, dor, tosse, eructação, asma relacionados ou não com gord, formulação farmacêutica, e, processo para a preparação de um composto | |
| BR0016291A (pt) | Composto, uso do mesmo, métodos para a inibição das relaxações do esfìncter esofágico inferior transientes, para o tratamento da doença do refluxo gastroesofágico, da regurgitação em bebês, de nocicepção, êmese, dispepsia, ibs, soluços, adicção de cocaìna, dor, tosse, eructação, asma relacionada ou não com gord, e, formulação farmacêutica | |
| Baumer et al. | Effects of acetorphan, an enkephalinase inhibitor, on experimental and acute diarrhoea. | |
| AU645023B2 (en) | Compositions and method for treating painful, inflammatory or allergic disorders | |
| BRPI0410477A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, método para a profilaxia ou tratamento de uma condição quiral em um mamìfero, formulação farmacêutica, combinação, uso de um composto, e, processo para preparar um composto | |
| BR0212251A (pt) | Composto e seus sais farmaceuticamente aceitáveis, composição farmacêutica, método para o tratamento preventivo e/ou terapêutico de uma doença ou distúrbio decorrente de proliferação celular anormal ou imprópria, e, uso do dito composto ou de um sal farmaceuticamente aceitável do mesmo | |
| BR9807950A (pt) | Composto, composição farmacêutica, uso de um composto, e, processos para tratar ou reduzir o risco de doenças ou condições humanas, o risco de doença inflamatória o risco da dor e para a preparação de um composto | |
| DE69111582D1 (de) | 1,4-Disubstituierte Piperazine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen. | |
| EP0123469B1 (en) | Use of fluoxetine for the manufacture of an anti-anxiety agent | |
| BRPI0410786A (pt) | composição, uso da mesma, e, método de tratamento de um distúrbio de humor em um paciente | |
| BRPI0408256A (pt) | composto, métodos de tratamento de um humano ou animal, pela limitação da replicação de células, que sofre de cáncer, que sofre de uma doença neoplástica, e que se sofre de doenças proliferativas, uso de um composto, e, processo para a preparação de um composto ou de um seu sal farmaceuticamente aceitável ou de um éster hidrolisável in vivo do mesmo | |
| BR0109672A (pt) | Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente | |
| BRPI0414780A (pt) | composto, uso do mesmo, composição farmacêutica, e, métodos para a terapia da dor em um animal de sangue quente, e para preparar um composto | |
| BRPI0411246A (pt) | composto, uso do mesmo, composição farmacêutica, e, métodos para terapia contra dor em um animal de sangue quente e para a preparação de um composto | |
| ATE257704T1 (de) | Pharmazeutische zusammensetzungen enthaltend norastemizol. | |
| BR9914266A (pt) | Derivados de propanolamina substituìdos por heterociclos, processos para a sua preparação, medicamentos contendo estes compostos e seu emprego | |
| HUT46658A (en) | Process for producing pharmaceutical compositions with lincotriene antagonist effect, comprising aromatic thioether derivatives as active ingredient | |
| BR0315320A (pt) | Composto ou sais farmaceuticamente aceitáveis dos mesmos, uso de um composto, composição farmacêutica, e, métodos para a terapia de dor em um animal de sangue quente e para produzir um composto | |
| BR0313278A (pt) | Compostos, processo para a preparação de um composto, composição farmacêutica que compreende o mesmo e sua utilização, método para o tratamento e profilaxia de enfermidades e obesidade e utilização dos compostos | |
| BR0311747A (pt) | Composição farmacêutica, forma de dose simples ou de múltiplas doses da composição, kit, e, método para tratar doença | |
| BR0314261A (pt) | Compostos, processo de preparação de um composto, composição farmacêutica que compreende o mesmo, utilização de um composto, método para tratamento e/ou profilaxia de enfermidades e utilização e/ou método de tratamento | |
| BR0308786A (pt) | Derivados de ftalimido como inibidores da monoamina oxidase b | |
| BRPI0515897A (pt) | composto, uso do mesmo, composição farmacêutica, e, método para a terapia de dor em um animal de sangue quente, e para a preparação de um composto | |
| BR0207866A (pt) | Uso de flumazenil na preparação de um medicamento para o tratamento da dependência de cocaìna | |
| BR0210153A (pt) | Composto, uso do mesmo, métodos para a inibição de relaxamentos transitórios do esfìncter esofágico inferior, para o tratamento de doença do refluxo gastro-esofágico e de regurgitação em crianças, e para o tratamento de asma, hipercinesia, eructação, tosse, dor, vìcio de cocaìna, retirada de álcool, dependência de nicotina, soluços, ibs, dispepsia, êmese ou nocicepção, e, formulação farmacêutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10(VIII) E 13 DA LPI |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |